egg albumin-derived peptide
Animal productexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 1, 2013 (NCT01981083)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- egg albumin-derived peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03709069 | N/A | Nov 10, 2018 | King Edward Medical University |
| NCT02223169 | N/A | Apr 1, 2014 | National University of Ireland |
| NCT01981083 | Phase 4 | Nov 1, 2013 | Centro Medico Lic Adolfo Lopez Mate |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Centro Medico Lic Adolfo Lopez Mate | Academic/Hospital | 1 | 1 | 1 | 2013 |
| King Edward Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| National University of Ireland | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1